-
Berberrubine chloride: Assay Workflows
2026-10-01
Berberrubine chloride connects inflammation, tumor biology, and urate-transport studies through a DMSO-compatible experimental workflow. This guide translates reference-backed ARPE-19 assays into practical cancer and hyperuricemia research strategies, with controls and troubleshooting steps for reproducible results.
-
HNRNPU K181 Lactylation Reprograms Cervical Cancer
2026-10-01
This Advanced Science study identifies HNRNPU K181 lactylation as a lactate-responsive mechanism that stabilizes HNRNPU, preserves PHGDH mRNA regulation, and sustains serine biosynthesis in cervical cancer. Its combination of transcriptomic, proteomic, molecular, metabolic, and in vivo analyses links a non-histone modification to tumor growth and suggests a framework for testing metabolic dependencies with carefully matched mechanistic controls.
-
A40926 Production Engineering in Nonomuraea
2026-09-30
Yushchuk and colleagues developed promoter-probe and regulatory-engineering tools for the genetically recalcitrant glycopeptide producer Nonomuraea gerenzanensis. Their results show that strengthening pathway-specific positive regulation can increase A40926 production and provide a rational alternative to trial-and-error strain improvement.
-
Annexin V-APC/7-AAD Apoptosis Kit Workflow
2026-09-30
Rapidly separate viable, apoptotic, late-apoptotic, and necrotic cells with a dual-parameter assay designed for both flow cytometry and fluorescence microscopy. The workflow translates cell-death biology into practical readouts for ccRCC immune-evasion studies, drug screening, and mixed tumor–immune cultures.
-
EZ Cap™ Reagent GG: Reliable Viability Workflows
2026-09-29
This scenario-driven guide shows how to evaluate EZ Cap™ Reagent GG (SKU B8177) within cell-viability and mRNA-related workflows without overstating undocumented performance. It combines assay controls, protocol optimization, interpretation safeguards, and a practical supplier-selection framework for more reproducible laboratory decisions.
-
Dicloxacillin Activity Against Intracellular S. aureus
2026-09-29
Sandberg and colleagues combined THP-1 cell assays with a murine peritonitis model to compare dicloxacillin activity against intracellular and extracellular Staphylococcus aureus. Their central finding was that free-drug time above the MIC best predicted efficacy in both compartments, while repeated dosing substantially improved bacterial reductions in vivo.
-
Haloprogin in Antifungal Research Workflows
2026-09-28
Haloprogin offers a useful research bridge between dermatophyte susceptibility testing and topical infection models, with reported activity against Candida and selected Gram-positive bacteria as well. This workflow-focused guide explains how to prepare assays, interpret MIC and MFC results, and troubleshoot vehicle or serum effects without treating historical findings as current clinical guidance.
-
Haloprogin Workflows for Antifungal Research
2026-09-27
Haloprogin pairs strong reported activity against dermatophytes with activity against Candida and selected Gram-positive bacteria, making it useful for comparative antimicrobial workflows. This guide translates a classic topical-infection study into practical in vitro and formulation-testing steps, with attention to vehicle controls, assay interpretation, and limits of the evidence.
-
X-Gal Beyond Blue-White Screening: Assay Boundaries
2026-09-26
X-Gal is best understood not only as a blue-white screening reagent, but as an enzyme-dependent readout with specific interpretive limits. This article connects its use in molecular cloning to a 2024 study of iRhom2 and olfactory signaling—while clarifying what the study does and does not establish about β-galactosidase assays.
-
Gepotidacin (GSK2140944) in Antibacterial Research
2026-09-26
Use Gepotidacin to connect whole-cell antibacterial activity with bacterial topoisomerase biology, including in studies of fluoroquinolone resistance. This workflow-focused guide covers concentration selection, orthogonal assays, and practical controls while distinguishing product data from a separate high-throughput target-discovery study.
-
8-Chloroadenosine for RNA Metabolism Research
2026-09-25
8-Chloroadenosine is a nucleoside analog described as an inhibitor of RNA synthesis and a research reagent for studying RNA-related processes. The RP3-340N1.2 study provides a complementary NSCLC example of RNA regulation, but it did not test 8-Chloroadenosine or establish its effects on IL-6.
-
From USP42 Biology to Biotin-Based Detection
2026-09-25
USP42 research in breast cancer illustrates why translational studies need assay strategies that connect pathway hypotheses to interpretable cell and tissue readouts. This article examines where biotin-based fluorescence can help, how to use Streptavidin – Cy5 thoughtfully, and what the evidence does—and does not—support.
-
AMG 9810: TRPV1 Antagonist for Sensory Research
2026-09-24
AMG 9810 is a selective competitive TRPV1 antagonist for studying stimulus-driven sensory signaling. Product information reports blockade of capsaicin-evoked calcium influx and CGRP release in cultured rat sensory neurons; these findings support mechanistic research, not a clinical treatment claim.
-
Cefepime as a Resistance-Ecology Probe in CREC
2026-09-24
Cefepime (BMY-28142) offers a useful phenotypic lens for studying how carbapenemase genes relate to antibiotic susceptibility in carbapenem-resistant Enterobacter cloacae. This article interprets recent multicenter findings and translates them into practical assay-design principles without treating gene detection as a substitute for susceptibility testing.
-
Mouse Neutrophil Cell Isolation Kit Workflow
2026-09-23
Build a rapid, column-free workflow for high-purity mouse neutrophil isolation from bone marrow, blood, or spleen. Negative selection keeps target cells unlabeled, making the preparation well suited to activation-sensitive tumor-immunity, nanovaccine, and functional assays.